Synplogen
About:
Synplogen is a synthetic biology firm that provide DNA synthesis and DNA library construction services.
Website: https://www.synplogen.com/
Top Investors: Spiber, i-nest capital
Description:
Synplogen is a start-up company that brings together unique DNA synthesis technologies that Kobe University and others have been developing for nearly 10 years. Utilizing state-of-the-art genetic engineering, information science, and robotics, Synplogen have the technology to synthesize high-throughput.
Total Funding Amount:
100M JPY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Kobe, Kyoto, Japan
Founded Date:
2017-02-27
Contact Email:
info(AT)synplogen.com
Founders:
Daniel Meyer, Kondo Akihiko, Sugahara Junichi, Tsuge Kenji
Number of Employees:
1-10
Last Funding Date:
2021-11-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai